Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer–from the body fluid to tissue level

J He, F Wu, Z Han, M Hu, W Lin, Y Li, M Cao - Frontiers in oncology, 2021 - frontiersin.org
In recent years, the diagnosis and treatment of colorectal cancer (CRC) have been
continuously improved, but the mortality rate continues to be high, especially in advanced …

Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods

M Mehrpouya, Z Pourhashem… - Journal of cellular …, 2019 - Wiley Online Library
In the last few years, there has been a growing interest in Cytokeratin 19 (CK19) studies in
the cancer research field. CK19 belongs to the Type I CKs, serves as a useful research tool …

Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis-an update

B Molnár, O Galamb, A Kalmár, BK Barták… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Screening methods for one of the most frequently diagnosed malignancy,
colorectal cancer (CRC), have limitations. Circulating cell-free nucleic acids (cfNA) hold …

Volatile organic compounds as a potential screening tool for neoplasm of the digestive system: A meta-analysis

L Wang, J Li, X Xiong, T Hao, C Zhang, Z Gao… - Scientific Reports, 2021 - nature.com
This meta-analysis was aimed to estimate the diagnostic performance of volatile organic
compounds (VOCs) as a potential novel tool to screen for the neoplasm of the digestive …

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer

S Derderian, Q Vesval, MD Wissing… - Clinical and …, 2022 - Wiley Online Library
Prostate cancer (PCa) clinical heterogeneity underscores tumor heterogeneity, which may
be best defined by cell subtypes. To test if cell subtypes contributing to progression can be …

[HTML][HTML] Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid …

LS Estévez Pérez, BO Alén, M Otero Alén… - International Journal of …, 2024 - mdpi.com
The early detection of tumors is one of the key factors in increasing overall survival in cancer
patients. A wide range of cancers still do not have a system of early diagnosis; therefore, the …

Protocol for the long‐term culture of human primary keratinocytes from the normal colorectal mucosa

E Torreggiani, M Rossini, I Bononi… - Journal of Cellular …, 2019 - Wiley Online Library
Procedures for in vitro culturing of human primary keratinocytes from normal colon mucosa
specimens have not been fully feasible, thus far. The protocol described herein allows …

[HTML][HTML] Circulating guanylyl cyclase C (GCC) mRNA is a reliable metastatic predictor and prognostic index of colorectal cancer

L Jiang, JG Feng, G Wang, YP Zhu, HX Ju… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background Currently, few specific biomarkers or standard cutoff values are available for
circulating tumor cells (CTCs) detection and survival prediction in patients with early stage …

[PDF][PDF] 子宫内膜癌患者外周血HMGA1, CK19 和CK20 水平分析

王亚玲 - 中国生育健康杂志, 2021 - cjrh.bjmu.edu.cn
目的检测子宫内膜癌(EC) 患者外周血高迁移率蛋白A1 (HMGA1), 细胞角蛋白19 (CK19)
和细胞角蛋白20 (CK20) 表达水平, 并探讨其临床意义. 方法回顾性分析2014 年1 月—2017 年6 …

Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2‑stage squamous cell carcinoma

Y Qi, W Li, S Kang, L Chen, M Hao… - Experimental and …, 2019 - spandidos-publications.com
Brain‑derived neurotrophic factor (BDNF), tropomyosin receptor kinase B (TrkB), vascular
endothelial growth factor (VEGF) and CD105 are highly expressed in several types of …